Patient characteristics:
A total of 149 HCV-infected cirrhotic patients (mean age of patients was 56.1±10.3 years, 77.9% male) meeting the inclusion and exclusion criteria were enrolled (Figure 1). Baseline patient characteristics are given in Table 1. Overall, 79 patients (53%) had no prior treatment for Hepatitis C (naïve), 51 patients (34.2%) had a history treatment failure with pegylated interferon alfa-2a with or without ribavirin, and the treatment history of 19 patients (12.8%) was not recorded. For treatment, 135 subjects (90.6%) received sofosbuvir 400mg, daclatasvir 60mg, and 1000 or 1200 mg of ribavirin for 12 weeks and 14 received (9.4%) only sofosbuvir and daclatasvir.